PMID 20079393</a><a href="/index.php/File:OA-icon.png" class="image"><img alt="OA-icon.png" src="https://media.snpedia.com/images/5/5b/OA-icon.png" width="15" height="15" />	2'-5'-Oligoadenylate synthetase single-nucleotide polymorphisms and haplotypes are associated with variations in immune responses to rubella vaccine
PMID 15732009</a><a href="/index.php/File:OA-icon.png" class="image"><img alt="OA-icon.png" src="https://media.snpedia.com/images/5/5b/OA-icon.png" width="15" height="15" />	Variation in antiviral 2',5'-oligoadenylate synthetase (2'5'AS) enzyme activity is controlled by a single-nucleotide polymorphism at a splice-acceptor site in the OAS1 gene.
PMID 19247438</a><a href="/index.php/File:OA-icon.png" class="image"><img alt="OA-icon.png" src="https://media.snpedia.com/images/5/5b/OA-icon.png" width="15" height="15" />	Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man.
